WO2006013750A1 - Food material having effect of controlling lipid metabolism, health food, animal feed and methd of feeding animal - Google Patents
Food material having effect of controlling lipid metabolism, health food, animal feed and methd of feeding animal Download PDFInfo
- Publication number
- WO2006013750A1 WO2006013750A1 PCT/JP2005/013630 JP2005013630W WO2006013750A1 WO 2006013750 A1 WO2006013750 A1 WO 2006013750A1 JP 2005013630 W JP2005013630 W JP 2005013630W WO 2006013750 A1 WO2006013750 A1 WO 2006013750A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- residue
- defatted
- weight
- animal
- animal feed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
- A23K10/37—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/115—Cereal fibre products, e.g. bran, husk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Definitions
- the present invention relates to a food material having a lipid metabolism regulating action and useful for preventing and improving obesity and lifestyle-related diseases, a health food, an animal feed, and a method for raising an animal fed with this animal feed. Is.
- rice bran contains a large amount of vegetable oil
- rice bran is used in large amounts as a raw material for cooking oil.
- Rice bran contains various nutrients such as vitamins, minerals and dietary fiber, and also contains a large amount of useful ingredients with various physiologically active functions. It is widely used as a raw material for feed additives.
- rice bran is used as a raw material for edible oil or when pharmaceuticals, food additives, feed additives, etc. are made from rice bran extract, rice bran koji and other products are extracted and then defatted rice bran ( A large amount of residue left after removal of oil with an organic solvent, etc., and residue (after removal of water-soluble components such as defatted residue).
- Patent Document 1 Japanese Patent Laid-Open No. 2001-327881
- Patent Document 2 JP 05-194069
- Patent Document 3 JP 05-199201 A
- a problem to be solved is that a large amount of defatted soot and residue are not effectively used. [0007] Therefore, the present inventors have intensively studied defatted lees and residues, and defatted lees and residues still have useful components, particularly components that have a function of regulating lipid metabolism in humans and animals, That is, it was discovered that a component having an action of increasing blood adiponectin concentration or lowering insulin resistance was considerably contained, and the present invention was made.
- the present invention focuses on the components remaining in defatted lees and residues, and regulates lipid metabolism in humans and animals to prevent or improve obesity and lifestyle-related diseases. Main features.
- the food material having a lipid metabolism regulating action according to the present invention is characterized in that it comprises defatted or residue.
- the health food having a lipid metabolism regulating action according to the present invention is characterized in that defatted koji or residue is one of the components.
- the lipid metabolism regulating action refers to an action that activates lipid metabolism in the human body or animal body to prevent or eliminate fattening and to prevent or eliminate lifestyle-related diseases.
- food materials are not only materials that can be consumed by humans, but also materials that can be used by animals for feed.
- the defatted koji is a koji that is obtained when kneading cereals.
- the degreasing strength also refers to the remaining residue obtained by extracting water-soluble components with water.
- the defatted residue or residue includes a fraction having an effect of increasing blood adiponectin concentration or decreasing insulin resistance.
- this fraction include hydroxycinnamic acid analog plant sterol esters. be able to.
- defatted lees and residues do not differ greatly in the effects of anti-obesity and anti-lifestyle diseases, and therefore the lees added to animal feed may be defatted lees or residues.
- the animal feed having a lipid metabolism regulating action according to the present invention is characterized in that defatted koji or residue is one of the components.
- the animal breeding method according to the present invention is characterized in that the animal is fed by feeding the animal feed using defatted straw or residue as one of the components.
- the basic components of the animal feed may be substantially the same as the animal feed generally used.
- the animal feed preferably contains a certain amount of lipid to improve eating.
- Lipids are included in feed raw materials from the beginning, and include fats and oils and fats and oils to which aftertaste is also added.
- the oils and fats added later include, for example, rapeseed oil, soybean oil, corn oil, palm oil, castor oil, lard, beef tallow, fish oil, whale oil, or one or more mixed oils selected from these oils. Can be mentioned.
- Animal feeds containing lipids contain 1 to 20% by weight of lipids and 1 to 15% by weight of defatted straw or residue (active ingredient hydroxycinnamic acid analog plant sterol esters As for the amount, about 20 to 300 / zg per lOOg of feed) can be mentioned.
- the reason why the lipid content is limited to 1 to 20% by weight is that if the lipid content is less than 1% by weight, the bite of pets and livestock becomes worse and the lipid content exceeds 20% by weight. It is the power that makes it difficult to form pellets as feed.
- the reason why the defatted residue or residue is limited to 1 to 15% by weight is that if the defatted residue or residue is less than 1% by weight, the anti-obesity effect or the residue is less than 15% by weight. If it exceeds the limit, other essential ingredients become too small, resulting in a feed with a poor nutritional balance. However, if the defatted lees or residue is 1 to 15% by weight, the nutritional balance is good and anti-obesity and anti-lifestyle-related diseases are effective. This is because
- the edible fats and oils are used as the lipids described above from the viewpoint that the effects of anti-obesity and anti-life-style related diseases are obtained in the animal feed and the animal breeding method having a lipid metabolism regulating action according to the present invention.
- the defatted lees or residues include a fraction having an effect of increasing blood adiponectin concentration or an effect of decreasing insulin resistance.
- this fraction include hydroxycinnamic acid analog plant sterol esters. This is the same as in the case of food materials and health foods described above.
- the invention's effect [0022] According to the present invention, it is possible to effectively use defatted lees and residues that have not been effectively used until now as raw materials for food ingredients, health foods, animal feeds, and the like. is there.
- a highly safe food material, health food, and the like that can improve the obesity of human beings, pets or livestock, and can prevent or improve lifestyle-related diseases such as diabetes. There is an effect that animal feed can be provided at low cost.
- FIG. 1 is a graph showing the relationship between residue content (% by weight) and blood adiponectin level (g / ml).
- FIG. 2 is a graph showing the relationship between residue content (% by weight) and obesity level (X 10 ′′ 2 g / m 2 ).
- FIG. 3 is a graph showing the effect of various components on adiponectin secretion in mouse 3T3-L1 adipocytes.
- FIG. 4 is a graph showing the HOMA insulin resistance index of mice used in the test.
- FIG. 5 is a graph showing the content (mg) of hydroxycinnamic acid analog plant sterol esters in 1 kg of rice bran and residue.
- FIG. 6 is a graph showing the content (mg) of hydroxycinnamic acid analog plant sterol esters in 1 kg of total lipid of rice bran and residue.
- mice were examined.
- An ELIS A measurement kit (Otsuka Pharmaceutical) was used for measurement of blood adiponectin levels.
- 3T3-L1 fibroblasts were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS) to reach confluence, then 1 ⁇ dexamethasone, 0.5 mM isobutyl. Differentiation was induced with 10% FB S DMEM containing methylxanthine and 5 / z gZml insulin.
- DMEM Dulbecco's modified Eagle's medium
- FBS fetal bovine serum
- hydroxycinnamic acid analog plant sterol ester significantly increased adiponectin secretion in 3T3-L1 adipocytes (P ⁇ 0. 01). ).
- other plant sterols, ferulic acid and cholesterol-added cocoon plots were stronger than the control plots.
- the active ingredients in the present invention are hydroxycinnamic acid analog plant sterol esters. it was thought.
- C57BL / 6Jcl mice were given a feed containing 5% residue and 10% edible oil or fat, or a feed containing no residue containing only 10% edible oil and fat. I was reared. Then, glucose was orally administered to each of these 5 mice, and blood glucose content and insulin level were quantified. The HOMA-IR index (insulin level before glucose load X blood glucose concentration Z22.5), which is an index of insulin resistance, was calculated using the results of this quantification. The results were as shown in the graph of FIG.
- Blood glucose was quantified using a glucose CII test kit from Wako Pure Chemical Industries, Ltd., and insulin was quantified using a Levis Insulin Mouse ELISA kit from Shibayagi Co., Ltd.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Polymers & Plastics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Nutrition Science (AREA)
- Child & Adolescent Psychology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Physiology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Emergency Medicine (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
Abstract
Description
明 細 書 Specification
脂質代謝調節作用を有する食品素材、健康食品、動物用飼料及び動物 の飼育方法 Food materials having a lipid metabolism-regulating effect, health foods, animal feed, and animal breeding methods
技術分野 Technical field
[0001] 本発明は脂質代謝調節作用を有し、肥満や生活習慣病の予防と改善に役立つ食 品素材、健康食品、動物用飼料及びこの動物用飼料を与えて飼育する動物の飼育 方法に関するものである。 [0001] The present invention relates to a food material having a lipid metabolism regulating action and useful for preventing and improving obesity and lifestyle-related diseases, a health food, an animal feed, and a method for raising an animal fed with this animal feed. Is.
背景技術 Background art
[0002] 米糠には植物性の油が大量に含まれているので、米糠は食用油の原料として大量 に使用されている。また、米糠にはビタミン、ミネラル、食物繊維など様々な栄養成分 が含まれる他に、種々の生理活性機能を有する有用な成分が大量に含まれている ので、その抽出物が薬剤、食品添加剤、飼料添加剤等の原料として広く利用されて いる。 [0002] Since rice bran contains a large amount of vegetable oil, rice bran is used in large amounts as a raw material for cooking oil. Rice bran contains various nutrients such as vitamins, minerals and dietary fiber, and also contains a large amount of useful ingredients with various physiologically active functions. It is widely used as a raw material for feed additives.
[0003] ところで、米糠が食用油の原料として使用される場合や米糠の抽出物から薬剤、食 品添加剤、飼料添加剤等が作られる場合、米糠カゝらこれらを抜き取った後に脱脂糠( 有機溶媒等で油分を除いた糠)、残滓糠 (脱脂糠カゝら更に水溶性成分を除いた滓) が大量に残る。 [0003] By the way, when rice bran is used as a raw material for edible oil or when pharmaceuticals, food additives, feed additives, etc. are made from rice bran extract, rice bran koji and other products are extracted and then defatted rice bran ( A large amount of residue left after removal of oil with an organic solvent, etc., and residue (after removal of water-soluble components such as defatted residue).
[0004] これら脱脂糠、残滓糠は上述した有用成分を抜き取った残り滓なので、有用成分は 残っていないだろうと思われ、含有成分の利用は全く考えられておらず、精米の助剤 [0004] Since these defatted koji and residue are the remaining koji from which the above-mentioned useful ingredients have been extracted, it seems that no useful ingredients remain, and the use of the ingredients is not considered at all.
、飼料の増量剤、堆肥の原料位にし力使われていな力つた。 It was not used as a feed extender or compost raw material.
[0005] 特許文献 1 :特開 2001— 327881 Patent Document 1: Japanese Patent Laid-Open No. 2001-327881
特許文献 2:特開平 05— 194069 Patent Document 2: JP 05-194069
特許文献 3 :特開平 05— 192091 Patent Document 3: JP 05-199201 A
発明の開示 Disclosure of the invention
発明が解決しょうとする課題 Problems to be solved by the invention
[0006] 解決しょうとする問題点は、大量に発生する脱脂糠や残滓糠が有効に利用されて いない点である。 [0007] そこで、本発明者等は脱脂糠、残滓糠にっ ヽて鋭意研究し、脱脂糠、残滓糠には まだ有用成分、特に人や動物の脂質の代謝を調節する働きを有する成分、すなわち 血中アディポネクチン濃度を上昇させたり、インスリン耐性を低下させる作用を有する 成分がかなり含まれていることを発見し、本発明をなすに至った。 [0006] A problem to be solved is that a large amount of defatted soot and residue are not effectively used. [0007] Therefore, the present inventors have intensively studied defatted lees and residues, and defatted lees and residues still have useful components, particularly components that have a function of regulating lipid metabolism in humans and animals, That is, it was discovered that a component having an action of increasing blood adiponectin concentration or lowering insulin resistance was considerably contained, and the present invention was made.
課題を解決するための手段 Means for solving the problem
[0008] 本発明は、脱脂糠、残滓糠中に残存している成分に着目して人や動物の脂質代謝 を調節し、肥満や生活習慣病を予防したり改善するようにしたことを最も主要な特徴 とする。 [0008] The present invention focuses on the components remaining in defatted lees and residues, and regulates lipid metabolism in humans and animals to prevent or improve obesity and lifestyle-related diseases. Main features.
[0009] すなわち、本発明に係る脂質代謝調節作用を有する食品素材は脱脂糠又は残滓 糠からなることを特徴とするものである。また、本発明に係る脂質代謝調節作用を有 する健康食品は脱脂糠又は残滓糠を成分の一つとしていることを特徴とするもので ある。 [0009] That is, the food material having a lipid metabolism regulating action according to the present invention is characterized in that it comprises defatted or residue. In addition, the health food having a lipid metabolism regulating action according to the present invention is characterized in that defatted koji or residue is one of the components.
[0010] ここで、脂質代謝調節作用とは、人間や動物の体内の脂質代謝を活性化させ、肥 満を予防したり解消させ、また生活習慣病を予防したり解消させる作用をいう。また、 食品素材とは、人間が摂取する食品の材料になる素材のみならず、動物が摂取する 飼料の材料になる素材を ヽぅ。 [0010] Here, the lipid metabolism regulating action refers to an action that activates lipid metabolism in the human body or animal body to prevent or eliminate fattening and to prevent or eliminate lifestyle-related diseases. In addition, food materials are not only materials that can be consumed by humans, but also materials that can be used by animals for feed.
[0011] また、脱脂糠とは、穀類を搗精する際に得られる糠力も nへキサン等の有機溶媒で 油分を抽出した残り滓あるいは圧搾によって油を絞り出した絞り滓を 、、残滓糠と は、脱脂糠力も水で水溶性成分を抽出した残り滓をいう。 [0011] In addition, the defatted koji is a koji that is obtained when kneading cereals. In addition, the degreasing strength also refers to the remaining residue obtained by extracting water-soluble components with water.
[0012] また、脱脂糠又は残滓糠は血中アディポネクチン濃度上昇作用又はインスリン耐性 を低下させる作用を有する画分を含んでおり、この画分としてはヒドロキシ桂皮酸類 縁体植物性ステロールエステル類を挙げることができる。 [0012] The defatted residue or residue includes a fraction having an effect of increasing blood adiponectin concentration or decreasing insulin resistance. Examples of this fraction include hydroxycinnamic acid analog plant sterol esters. be able to.
[0013] なお、脱脂糠と残滓糠は抗肥満および抗生活習慣病の効果に大差はな 、ので、 動物用飼料に添加する糠は、脱脂糠でもよいし、残滓糠でもよい。 [0013] It should be noted that defatted lees and residues do not differ greatly in the effects of anti-obesity and anti-lifestyle diseases, and therefore the lees added to animal feed may be defatted lees or residues.
[0014] また、本発明に係る脂質代謝調節作用を有する動物用飼料は脱脂糠又は残滓糠 を成分の一つとしていることを特徴とするものである。また、本発明に係る動物の飼育 方法は、脱脂糠又は残滓糠を成分の一つとして 、る動物用飼料を与えて動物を飼 育することを特徴とするものである。 [0015] ここで、動物用飼料の基本的成分は一般に使用されている動物用飼料と略同一で よい。また、動物用飼料は食い付きを良くするために有る程度の脂質が含まれている ものが好ましい。 [0014] Further, the animal feed having a lipid metabolism regulating action according to the present invention is characterized in that defatted koji or residue is one of the components. In addition, the animal breeding method according to the present invention is characterized in that the animal is fed by feeding the animal feed using defatted straw or residue as one of the components. [0015] Here, the basic components of the animal feed may be substantially the same as the animal feed generally used. The animal feed preferably contains a certain amount of lipid to improve eating.
[0016] 脂質には、飼料の原料に初めから含まれて 、た油脂類や、後力も添加した油脂類 が含まれる。後から添加した油脂類としては、例えばなたね油、大豆油、コーン油、 やし油、ひまし油、豚脂、牛脂、魚油、鯨油又はこれらの油から選択された 1種又は 2 種以上の混合油を挙げることができる。 [0016] Lipids are included in feed raw materials from the beginning, and include fats and oils and fats and oils to which aftertaste is also added. The oils and fats added later include, for example, rapeseed oil, soybean oil, corn oil, palm oil, castor oil, lard, beef tallow, fish oil, whale oil, or one or more mixed oils selected from these oils. Can be mentioned.
[0017] 脂質が含まれている動物用飼料としては、脂質を 1〜20重量%含有し、且つ脱脂 糠又は残滓糠を 1〜15重量% (有効成分ヒドロキシ桂皮酸類縁体植物性ステロール エステル類量として飼料 lOOgあたり 20〜300 /z g程度)含有するものを挙げることが できる。 [0017] Animal feeds containing lipids contain 1 to 20% by weight of lipids and 1 to 15% by weight of defatted straw or residue (active ingredient hydroxycinnamic acid analog plant sterol esters As for the amount, about 20 to 300 / zg per lOOg of feed) can be mentioned.
[0018] 脂質の含有量を 1〜20重量%と限定した理由は、脂質の含有量が 1重量%未満で はペットや家畜の食い付きが悪くなり、脂質の含有量が 20重量%を越えると飼料とし てのペレット成形が困難になる力 である。 [0018] The reason why the lipid content is limited to 1 to 20% by weight is that if the lipid content is less than 1% by weight, the bite of pets and livestock becomes worse and the lipid content exceeds 20% by weight. It is the power that makes it difficult to form pellets as feed.
[0019] また、脱脂糠又は残滓糠を 1〜15重量%と限定した理由は、脱脂糠又は残滓糠が 1重量%未満では抗肥満の効果が小さぐ脱脂糠又は残滓糠が 15重量%を越えると 他の必須成分が少なくなり過ぎ、栄養バランスの悪い飼料になってしまうが、脱脂糠 又は残滓糠を 1〜15重量%とすれば栄養バランスが良く且つ抗肥満および抗生活 習慣病の効果が得られるからである。 [0019] The reason why the defatted residue or residue is limited to 1 to 15% by weight is that if the defatted residue or residue is less than 1% by weight, the anti-obesity effect or the residue is less than 15% by weight. If it exceeds the limit, other essential ingredients become too small, resulting in a feed with a poor nutritional balance. However, if the defatted lees or residue is 1 to 15% by weight, the nutritional balance is good and anti-obesity and anti-lifestyle-related diseases are effective. This is because
[0020] なお、本発明に係る脂質代謝調節作用を有する動物用飼料及び動物の飼育方法 において、抗肥満および抗生活習慣病の顕著な効果が得られるという見地から、前 記脂質として食用油脂類が 3〜10重量%、前記脱脂糠又は残滓糠が 5〜10重量% の範囲が特に好ましい。 [0020] It should be noted that the edible fats and oils are used as the lipids described above from the viewpoint that the effects of anti-obesity and anti-life-style related diseases are obtained in the animal feed and the animal breeding method having a lipid metabolism regulating action according to the present invention. Is preferably 3 to 10% by weight, and the defatted soot or residue is preferably 5 to 10% by weight.
[0021] また、脱脂糠又は残滓糠は血中アディポネクチン濃度上昇作用又はインスリン耐性 を低下させる作用を有する画分を含んでおり、この画分としてはヒドロキシ桂皮酸類 縁体植物性ステロールエステル類が挙げられることは、上述した食品素材や健康食 品の場合と同様である。 [0021] Further, the defatted lees or residues include a fraction having an effect of increasing blood adiponectin concentration or an effect of decreasing insulin resistance. Examples of this fraction include hydroxycinnamic acid analog plant sterol esters. This is the same as in the case of food materials and health foods described above.
発明の効果 [0022] 本発明によれば、今まで有効に利用されていな力つた脱脂糠や残滓糠を、食品素 材、健康食品、動物用飼料等の原料として有効に利用することができるという効果が ある。 The invention's effect [0022] According to the present invention, it is possible to effectively use defatted lees and residues that have not been effectively used until now as raw materials for food ingredients, health foods, animal feeds, and the like. is there.
[0023] また、本発明によれば、人間やペット又は家畜の肥満の体質を改善し、糖尿病など の生活習慣病を予防したり改善させることができる安全性の高い食品素材、健康食 品及び動物用飼料を安価に提供することができるという効果がある。 [0023] Further, according to the present invention, a highly safe food material, health food, and the like that can improve the obesity of human beings, pets or livestock, and can prevent or improve lifestyle-related diseases such as diabetes. There is an effect that animal feed can be provided at low cost.
[0024] また、本発明によれば、油分を添加して食べ易くしても、摂取する人間やペット又は 家畜が肥満や糖尿病などになり難!ヽ食品素材、健康食品及び動物用飼料を提供す ることができると!/、う効果がある。 [0024] Further, according to the present invention, even if it is easy to eat with the addition of oil, it is difficult for humans, pets or livestock to ingest it to become obese or diabetic! ヽ Provides food materials, health foods and animal feed If you can!
図面の簡単な説明 Brief Description of Drawings
[0025] [図 1]残滓糠の含有量 (重量%)と血中アディポネクチン値 g/ml)との関係を示 すグラフである。 [0025] FIG. 1 is a graph showing the relationship between residue content (% by weight) and blood adiponectin level (g / ml).
[図 2]残滓糠の含有量 (重量%)と肥満度( X 10"2g/m2)との関係を示すグラフであ る。 FIG. 2 is a graph showing the relationship between residue content (% by weight) and obesity level (X 10 ″ 2 g / m 2 ).
[図 3]マウス 3T3— L1脂肪細胞におけるアディポネクチン分泌量に及ぼす各種成分 の効果を示すグラフである。 FIG. 3 is a graph showing the effect of various components on adiponectin secretion in mouse 3T3-L1 adipocytes.
[図 4]試験に用いたマウスの HOMAインスリン耐性インデックスを示すグラフである。 FIG. 4 is a graph showing the HOMA insulin resistance index of mice used in the test.
[図 5]米糠及び残滓糠各 lkg中のヒドロキシ桂皮酸類縁体植物性ステロールエステル 類の含有量 (mg)を示すグラフである。 FIG. 5 is a graph showing the content (mg) of hydroxycinnamic acid analog plant sterol esters in 1 kg of rice bran and residue.
[図 6]米糠及び残滓糠について、含有全脂質 lkg中のヒドロキシ桂皮酸類縁体植物 性ステロールエステル類の含有量 (mg)を示すグラフである。 発明を実施するための最良の形態 FIG. 6 is a graph showing the content (mg) of hydroxycinnamic acid analog plant sterol esters in 1 kg of total lipid of rice bran and residue. BEST MODE FOR CARRYING OUT THE INVENTION
[0026] 人間やペット又は家畜の肥満の体質を改善し、糖尿病などの生活習慣病を予防し たり改善させるという目的を、低コストで、安全性を損なわずに実現した。 [0026] The purpose of improving the obesity of human beings, pets or livestock, and preventing or improving lifestyle diseases such as diabetes has been achieved at low cost without compromising safety.
実施例 1 Example 1
[0027] 平成 13年度広島産コシヒカリより得られた米糠 200gに対し、 1リットルの特級へキサ ンを加え、カップ型ホモジナイザーで 12000回転、 5分間均一に撹拌した後、 No. 1 濾紙にて吸引濾過を行った。この操作を再度繰り返した後、得られた脱脂糠をエバ ボレーターにてへキサン除去した。 [0027] To 200 g of rice bran obtained from Hiroshima-grown Koshihikari in 2001, add 1 liter of special grade hexane, stir uniformly with a cup-type homogenizer for 12,000 revolutions for 5 minutes, and then suction with No. 1 filter paper Filtration was performed. After repeating this operation again, Hexane was removed with a borator.
[0028] 次に、得られた脱脂糠に 2倍量の蒸留水をカ卩え、カップ型ホモジナイザーで 12000 回転、 5分間均一に撹拌した後、 5000xg、 20分間の遠心分離にて糠を沈殿として 回収した。再度、蒸留水によって水溶性成分を抽出し、遠心分離後、得られた残滓 糠をエバポレーターおよび室温放置によって乾燥させた。 [0028] Next, after adding 2 volumes of distilled water to the defatted cocoon obtained, stirring it uniformly with a cup-type homogenizer for 12000 revolutions for 5 minutes, and then centrifuging at 5000 xg for 20 minutes As recovered. Again, water-soluble components were extracted with distilled water, and after centrifugation, the resulting residue was dried by leaving it at room temperature with an evaporator.
[0029] 次に、表 1に示すように、上記のようにして得られた残滓糠を 0〜 15重量%、食用油 脂類を 1〜20重量%、含有する試験飼料を作製した。また、表 1に示す成分中、残 滓糠の代わりに粗繊維としてセルロースを 5重量0 /0、食用油としてコーン油を 6重量 %とした標準飼料を作成した。 [0029] Next, as shown in Table 1, a test feed containing 0 to 15% by weight of the residue obtained as described above and 1 to 20% by weight of edible fats and oils was prepared. Further, in the component shown in Table 1, 5 parts by weight of cellulose as a crude fiber instead of remaining Kasunuka 0/0, created a standard diet which was 6% by weight of corn oil as an edible oil.
[0030] [表 1] [0030] [Table 1]
[0031] 次に、明暗(12hZl2h)および 23°Cに調節された実験動物飼育施設中において [0031] Next, in a laboratory animal facility adjusted to light and dark (12hZl2h) and 23 ° C
7週令の C57BLZ6J Jclマウス雄 120尾を無作為に 30群に分け、 4尾ずつケージ に入れて飼育を行った。 120 male 7-week-old C57BLZ6J Jcl mice were randomly divided into 30 groups, and 4 males were housed in cages.
[0032] まず、予備飼育として 1週間、標準飼料を投与して飼育し、その後、 3週にわたって 試験飼料を投与した。飼料はマウスに飽食摂取させるために一匹一日あたり約 5gを 投与した。 [0032] First, as a preliminary breeding, a standard feed was administered for 1 week for breeding, and then a test diet was administered for 3 weeks. About 5 g per day was administered to feed the mouse as a food intake.
[0033] 次に、マウスの肥満度(X 10_2g/m2)及び血中アディポネクチン値( g/ml)を 調べたところ、表 2に示す通りであった。血中アディポネクチン値の測定には、 ELIS A測定キット (大塚製薬)を用いた。 Next, the obesity level (X 10 _2 g / m 2 ) and blood adiponectin level (g / ml) of mice were examined. An ELIS A measurement kit (Otsuka Pharmaceutical) was used for measurement of blood adiponectin levels.
[0034] [表 2] 食用油脂 残滓糠 肥満度 血中ァ亍'ィホ 'ネクチン値 [0034] [Table 2] Edible oils and fats Residue Obesity Blood key 'Nejo' Nectin level
言式料 Language fee
(重量%) (重量%) (x10"2g/m2) ( g/ml) (Wt%) (wt%) (x10 "2 g / m 2) (g / ml)
1 1 0 24.3 0.8 1 1 0 24.3 0.8
2 1 1 24.5 1.8 2 1 1 24.5 1.8
3 1 5 24.4 2.2 3 1 5 24.4 2.2
4 1 10 24.6 2.8 4 1 10 24.6 2.8
5 1 15 25.1 3.2 5 1 15 25.1 3.2
6 3 0 25.8 0.7 6 3 0 25.8 0.7
7 3 1 25.2 1.7 7 3 1 25.2 1.7
8 3 5 25.6 2.1 8 3 5 25.6 2.1
9 3 10 25.4 2.9 9 3 10 25.4 2.9
10 3 15 24.5 3.4 10 3 15 24.5 3.4
11 5 0 26.8 1.0 11 5 0 26.8 1.0
12 5 1 26.5 1.9 12 5 1 26.5 1.9
13 5 5 25.0 2.6 13 5 5 25.0 2.6
14 5 10 24.8 3.1 14 5 10 24.8 3.1
15 5 15 24.4 3.4 15 5 15 24.4 3.4
16 10 0 27.9 1.2 16 10 0 27.9 1.2
17 10 1 28.2 1.8 17 10 1 28.2 1.8
18 10 5 25.2 2.7 18 10 5 25.2 2.7
19 10 10 24.4 3.0 19 10 10 24.4 3.0
20 10 15 24.6 3.2 20 10 15 24.6 3.2
21 15 0 28.8 0.9 21 15 0 28.8 0.9
22 15 1 29.5 2.1 22 15 1 29.5 2.1
23 15 5 26.2 2.5 23 15 5 26.2 2.5
24 15 10 26.1 3.1 24 15 10 26.1 3.1
25 15 15 26.2 3.5 25 15 15 26.2 3.5
26 20 0 31.6 0.9 26 20 0 31.6 0.9
27 20 1 30.9 1.9 27 20 1 30.9 1.9
28 20 5 29.5 2.4 28 20 5 29.5 2.4
29 20 10 28.8 3.2 29 20 10 28.8 3.2
30 20 15 27.9 3.3 30 20 15 27.9 3.3
[0035] 表 2に示された結果を元に作成した図 1から、残滓糠力 ^重量%の場合のマウスの 血中アディポネクチン値 g/ml)と比較して、残滓糠が 1重量%以上ではマウスの 血中アディポネクチン値 g/ml)が高くなることがわかる。また、残滓糠の含有量( 重量0 /0)が増えるにつれてマウスの血中アディポネクチン値( g/ml)が高くなること がわカゝる。 [0035] From FIG. 1, which was created based on the results shown in Table 2, the amount of residual was 1% by weight or more compared to the blood adiponectin level in mice with residual power of ^% by weight (g / ml). Shows that the blood adiponectin level in mice (g / ml) increases. The content of residue bran (wt 0/0) of blood adiponectin levels in the mice as increased (g / ml) is higher Gawakakaru.
[0036] また、表 2に示された結果を元に作成した図 2から、残滓糠が 0重量%の場合のマウ スの肥満度( X 10"2g/m2)と比較して、残滓糠が 1重量%以上ではマウスの肥満度 (X10"2g/m2)が低くなることがわかる。ここで、肥満度においては、短期的には、 残滓糠 1%では効果が緩慢であると考えられるが、 5%になると、短期的にも効果が 認められてくることがわ力る。また、残滓糠の含有量 (重量%)が増えるにつれて肥満 度(X 10_2g/m2)が低くなることがわかる。なお、食用油脂が 15重量%を越えた場 合、飼料をペレット状に成形することが困難であった。 [0036] From FIG. 2, which was created based on the results shown in Table 2, compared to the obesity level of the mouse (X 10 " 2 g / m 2 ) when the residue is 0% by weight, It can be seen that the obesity level of the mouse (X10 " 2 g / m 2 ) is low when the residue is 1% by weight or more. Here, in terms of obesity, in the short term, the effect is considered to be slow with the remaining 1%, but when it becomes 5%, the effect is also in the short term. It is powerful to be recognized. It can also be seen that the obesity (X 10 _2 g / m 2 ) decreases as the residue content (% by weight) increases. When edible fats and oils exceeded 15% by weight, it was difficult to form feed into pellets.
[0037] 次に、抗肥満および抗生活習慣病効果を示す有効成分を明らかにするための実 験を行った。 [0037] Next, an experiment was conducted to clarify the active ingredients having anti-obesity and anti-lifestyle disease effects.
[0038] 穀類糠において、 n キサンのような非極性溶媒によって抽出されにくぐクロ口 ホルム'メタノール混合溶媒などの比較的極性の高い溶媒によって抽出されやすい 画分には、植物性ステロール、フェルラ酸、植物性ステロールフェルラ酸エステル類 などが存在する。そこで、これらの標品もしくは混合物による脂肪細胞のアディポネク チン分泌調節作用につ!、て検討を加えた。 [0038] In cereal meals, it is difficult to extract with a relatively polar solvent such as Kuroguchi Form'methanol mixed solvent, which is difficult to extract with a non-polar solvent such as n-xan. And plant sterol ferulic acid esters. Therefore, we examined the effects of these preparations or mixtures on the adiponectin secretion regulation of adipocytes.
[0039] ポジティブコントロールとして、 2型糖尿病治療薬として用いられ、脂肪細胞のアディ ポネクチン分泌を増強することが既に知られて 、るトログリタゾン、試験物質として植 物性ステロール混合物、コレステロール、ヒドロキシ桂皮酸類縁体植物性ステロール エステル、フェルラ酸を用い、これらがマウス脂肪細胞によるアディポネクチン分泌に 及ぼす影響を調べた。 [0039] As a positive control, used as a therapeutic agent for type 2 diabetes, already known to enhance adiponectin secretion in adipocytes, troglitazone, plant sterol mixture as test substance, cholesterol, hydroxycinnamic acid analog Using plant sterol esters and ferulic acid, we investigated the effects of these on adiponectin secretion by mouse adipocytes.
[0040] すなわち、 3T3— L1線維芽細胞を 10%牛胎児血清 (FBS)を含むダルベッコ改変 イーグル培地(DMEM)にて培養してコンフルェントに達した後、 1 μ Μデキサメサゾ ン、 0. 5mMイソブチルメチルキサンチンおよび 5 /z gZmlインスリンを含む 10%FB S DMEMにて分化誘導した。 [0040] That is, 3T3-L1 fibroblasts were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS) to reach confluence, then 1 μΜ dexamethasone, 0.5 mM isobutyl. Differentiation was induced with 10% FB S DMEM containing methylxanthine and 5 / z gZml insulin.
[0041] 7日後、分ィ匕した 3T3— L1脂肪細胞に 1 μ molZlの上述の試験物質を含む 10% FBS - DMEMを投与し、 24時間後に培養上清を採取してアディポネクチン ELIS A キット(大塚製薬)にてアディポネクチン濃度を測定したところ、図 3に示す通りであつ た。 [0041] After 7 days, 10% FBS-DMEM containing 1 μmolZl of the above test substance was administered to the separated 3T3-L1 adipocytes. After 24 hours, the culture supernatant was collected and the adiponectin ELIS A kit ( Adiponectin concentration was measured by Otsuka Pharmaceutical Co., Ltd. and as shown in Fig. 3.
[0042] 図 3に示すように、トログリタゾン添カ卩区と同様に、ヒドロキシ桂皮酸類縁体植物性ス テロールエステルは 3T3—L1脂肪細胞におけるアディポネクチン分泌を有意に増 強した(P< 0. 01)。一方、他の植物性ステロール、フェルラ酸およびコレステロール 添カ卩区ではコントロール区と比して差が認められな力つた。以上のことから、本発明に おける有効成分はヒドロキシ桂皮酸類縁体植物性ステロールエステル類であるものと 考えられた。 [0042] As shown in Fig. 3, similar to troglitazone-added cocoon, hydroxycinnamic acid analog plant sterol ester significantly increased adiponectin secretion in 3T3-L1 adipocytes (P <0. 01). ). On the other hand, other plant sterols, ferulic acid and cholesterol-added cocoon plots were stronger than the control plots. Based on the above, the active ingredients in the present invention are hydroxycinnamic acid analog plant sterol esters. it was thought.
実施例 2 Example 2
[0043] C57BL/6Jclマウスに、 5%残滓糠と 10%食用油脂とを含む飼料あるいは 10%食用 油脂だけを含む残滓糠を含まない飼料を与え、実施例 1と同様にして、 3週間に亘っ て飼育した。そして、これらのマウス 5尾ずつについてグルコースを経口投与し、血液 中グルコース含量およびインスリンレベルを定量した。そして、この定量の結果を用い てインスリン耐性の指標である HOMA-IRインデックス(糖負荷前のインスリンレベル X 血中グルコース濃度 Z22. 5)を算出した。結果は図 4のグラフに示す通りであった。 [0043] C57BL / 6Jcl mice were given a feed containing 5% residue and 10% edible oil or fat, or a feed containing no residue containing only 10% edible oil and fat. I was reared. Then, glucose was orally administered to each of these 5 mice, and blood glucose content and insulin level were quantified. The HOMA-IR index (insulin level before glucose load X blood glucose concentration Z22.5), which is an index of insulin resistance, was calculated using the results of this quantification. The results were as shown in the graph of FIG.
[0044] なお、血中グルコースについては和光純薬工業株式会社のグルコース CII テスト ヮコーキットを用いて定量し、インスリンについては株式会社シバヤギのレビスインスリ ン マウス ELISAキットを用 、て定量した。 [0044] Blood glucose was quantified using a glucose CII test kit from Wako Pure Chemical Industries, Ltd., and insulin was quantified using a Levis Insulin Mouse ELISA kit from Shibayagi Co., Ltd.
[0045] 図 4に示す通り、残滓糠を含有する試験飼料を用いた区で明らかにインスリン耐性 が低下し、改善されていることがわかる。従って、残滓糠を摂取したマウスではインス リン耐性が改善され、インスリンによる血糖低下が速やかに起こること、すなわち残滓 糠には 2型糖尿病を改善する作用が存在することがわかる。 [0045] As shown in Fig. 4, it can be seen that insulin resistance was clearly reduced and improved in the group using the test feed containing residue. Therefore, it can be seen that in mice taking residue, insulin resistance is improved and insulin-induced hypoglycemia occurs rapidly, that is, residue has an effect of improving type 2 diabetes.
実施例 3 Example 3
[0046] 米糠および残滓糠カゝらクロ口ホルム'メタノール混合溶媒にて全脂質を抽出し、 HPL C分析によってヒドロキシ桂皮酸類縁体植物性ステロールエステル類を定量した。そ して、糠 lkg当たりのヒドロキシ桂皮酸類縁体植物性ステロールエステル類 (mg)として 表したところ、図 5に示す通りであった。この結果から、残滓糠には米糠に匹敵する量 のヒドロキシ桂皮酸類縁体植物性ステロールエステル類が残存していることがわかる [0046] Total lipids were extracted with a mixed solvent of koji and formaldehyde from rice bran and residue koji, and hydroxycinnamic acid analog plant sterol esters were quantified by HPLC analysis. And, when expressed as hydroxycinnamic acid analog plant sterol esters (mg) per 1 kg, it was as shown in FIG. From this result, it is understood that the amount of hydroxycinnamic acid analog plant sterol esters remaining in the residue is comparable to that of rice bran.
[0047] また、上記定量の結果を、全脂質 lkg当たりのヒドロキシ桂皮酸類縁体植物性ステ ロールエステル類 (mg)として表したところ、図 6に示す通りであった。この結果から、全 脂質当たりのヒドロキシ桂皮酸類縁体植物性ステロールエステル類の濃度は、残滓 糠では米糠の 4倍以上も高ぐ特異的に残存していることが分かる。 [0047] The results of the above quantification were expressed as hydroxycinnamic acid analog plant sterol esters ( mg ) per kg of total lipid, as shown in FIG. From this result, it can be seen that the concentration of hydroxycinnamic acid analog plant sterol esters per total lipid remains specifically more than four times higher than that of rice bran.
Claims
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006531398A JP4785140B2 (en) | 2004-08-04 | 2005-07-26 | Food material having lipid metabolism regulating action, health food, animal feed and animal breeding method |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004227822 | 2004-08-04 | ||
| JP2004-227822 | 2004-08-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2006013750A1 true WO2006013750A1 (en) | 2006-02-09 |
Family
ID=35787040
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2005/013630 Ceased WO2006013750A1 (en) | 2004-08-04 | 2005-07-26 | Food material having effect of controlling lipid metabolism, health food, animal feed and methd of feeding animal |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP4785140B2 (en) |
| WO (1) | WO2006013750A1 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008099448A1 (en) * | 2007-02-09 | 2008-08-21 | Masayoshi Yamaguchi | Preventive/therapeutic agent for diabetic diseases |
| JP2011063554A (en) * | 2009-09-18 | 2011-03-31 | Tokyo Univ Of Marine Science & Technology | Adiponectin secretion regulator |
| US9943517B2 (en) | 2012-11-13 | 2018-04-17 | Nusirt Sciences, Inc. | Compositions and methods for increasing energy metabolism |
| US10076507B1 (en) | 2011-07-15 | 2018-09-18 | Nusirt Sciences, Inc. | Compositions and methods for modulating metabolic pathways |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014149280A1 (en) * | 2013-03-15 | 2014-09-25 | Nusirt Sciences, Inc. | Treatment of pets with sirtuin activators |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0725779A (en) * | 1993-06-25 | 1995-01-27 | Yakurigaku Chuo Kenkyusho:Kk | Lipase inhibitor derived from embryo bud of defatted rice |
| JP2001097880A (en) * | 1999-09-28 | 2001-04-10 | Otsuka Pharmaceut Factory Inc | Lipase inhibitor from defatted bran |
| JP2002316939A (en) * | 2001-04-18 | 2002-10-31 | Real:Kk | alpha-GLUCOSIDASE INHIBITOR AND PROCESSED FOOD, HYPERGLYCEMIA MEDICINE, FEED AND ADDITIVE CONTAINING THE SAME |
| JP2004091462A (en) * | 2002-09-02 | 2004-03-25 | Oriza Yuka Kk | Carbohydrate absorption inhibitor |
| JP2005068132A (en) * | 2003-08-06 | 2005-03-17 | Enkaku Iryo Kenkyusho:Kk | Adiponectin secretion promoter, and anti-arteriosclerosis agent, anti-obesity agent, antidiabetic mellitus agent, food additive, functional food and feed additive containing adiponectin secretion promoter |
-
2005
- 2005-07-26 JP JP2006531398A patent/JP4785140B2/en not_active Expired - Lifetime
- 2005-07-26 WO PCT/JP2005/013630 patent/WO2006013750A1/en not_active Ceased
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0725779A (en) * | 1993-06-25 | 1995-01-27 | Yakurigaku Chuo Kenkyusho:Kk | Lipase inhibitor derived from embryo bud of defatted rice |
| JP2001097880A (en) * | 1999-09-28 | 2001-04-10 | Otsuka Pharmaceut Factory Inc | Lipase inhibitor from defatted bran |
| JP2002316939A (en) * | 2001-04-18 | 2002-10-31 | Real:Kk | alpha-GLUCOSIDASE INHIBITOR AND PROCESSED FOOD, HYPERGLYCEMIA MEDICINE, FEED AND ADDITIVE CONTAINING THE SAME |
| JP2004091462A (en) * | 2002-09-02 | 2004-03-25 | Oriza Yuka Kk | Carbohydrate absorption inhibitor |
| JP2005068132A (en) * | 2003-08-06 | 2005-03-17 | Enkaku Iryo Kenkyusho:Kk | Adiponectin secretion promoter, and anti-arteriosclerosis agent, anti-obesity agent, antidiabetic mellitus agent, food additive, functional food and feed additive containing adiponectin secretion promoter |
Non-Patent Citations (3)
| Title |
|---|
| "BOSO Yushi, Shin Yushi no Tokusei to Oyo Kome Abura (sono 2)", YUSHI, vol. 51, no. 1, 1998, pages 76 - 81, XP002997747 * |
| TSUJIWAKI S.: "Komenuka Seibun no Seiri Kassei Kino", SHOKUHIN TO KAGAKU, vol. 43, no. 8, 2001, pages 75 - 80, XP002997749 * |
| YAMASAKI T. ET AL: "Defatted rice bran intake raises serum adiponectin levels in mouse", SEIKAGAKU, vol. 76, no. 8, 25 August 2004 (2004-08-25), pages 1114, XP002997748 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008099448A1 (en) * | 2007-02-09 | 2008-08-21 | Masayoshi Yamaguchi | Preventive/therapeutic agent for diabetic diseases |
| JP2011063554A (en) * | 2009-09-18 | 2011-03-31 | Tokyo Univ Of Marine Science & Technology | Adiponectin secretion regulator |
| US10076507B1 (en) | 2011-07-15 | 2018-09-18 | Nusirt Sciences, Inc. | Compositions and methods for modulating metabolic pathways |
| US10383837B2 (en) | 2011-07-15 | 2019-08-20 | Nusirt Sciences, Inc. | Compositions and methods for modulating metabolic pathways |
| US9943517B2 (en) | 2012-11-13 | 2018-04-17 | Nusirt Sciences, Inc. | Compositions and methods for increasing energy metabolism |
| US10646489B2 (en) | 2012-11-13 | 2020-05-12 | Nusirt Sciences, Inc. | Compositions and methods for increasing energy metabolism |
Also Published As
| Publication number | Publication date |
|---|---|
| JP4785140B2 (en) | 2011-10-05 |
| JPWO2006013750A1 (en) | 2008-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fischer et al. | Comparing black soldier fly (Hermetia illucens) larvae versus prepupae in the diets of largemouth bass, Micropterus salmoides: Effects on their growth, biochemical composition, histopathology, and gene expression | |
| Fontanari et al. | Cholesterol-lowering effect of whole lupin (Lupinus albus) seed and its protein isolate | |
| Ryan | Bioactive food components and health properties of rice bran | |
| Plate et al. | Cholesterol-lowering effect of extruded amaranth (Amaranthus caudatus L.) in hypercholesterolemic rabbits | |
| US20100086638A1 (en) | Feed formulations containing docosahexaenoic acid | |
| Huang et al. | The effect of adlay oil on plasma lipids, insulin and leptin in rat | |
| Wiklund et al. | Fatty acid composition of M. longissimus lumborum, ultimate muscle pH values and carcass parameters in reindeer (Rangifer tarandus tarandus L) grazed on natural pasture or fed a commercial feed mixture | |
| DE69832520T2 (en) | USE OF CONJUGATED LINOLEIC ACID FOR THE TREATMENT OF TYPE II DIABETES | |
| CN105661079A (en) | Pet food compositions and methods for weight loss and maintenance | |
| Santoso et al. | Effect of Sauropus androgynus (Katuk) extract on egg production and lipid metabolism in layers | |
| JP2009291187A (en) | Food composition for improving eating habit | |
| Porcino et al. | Review on alternative meals for gilthead seabream, Sparus aurata | |
| Sulistyowati et al. | Quality of milk fatty acid during late lactation in dairy goat fed on PUFA-diet supplemented with yeast and | |
| WO2006013750A1 (en) | Food material having effect of controlling lipid metabolism, health food, animal feed and methd of feeding animal | |
| Rouag et al. | The effect of oral gavage (force-feeding) administration of fenugreek seeds (Trigonella foenum-graecum L.) on biochemical and neurobehavioural parameters in male Wistar rats | |
| Sanchez-Muniz et al. | Prevention of dietary hypercholesterolemia in rats using sunflower-oil-fried sardines. Effects on cholesterol and serum enzymes | |
| Suruga et al. | Okara” a new preparation of food material with antioxidant activity and dietary fiber from soybean | |
| Sbardella et al. | Rice oil as a soybean oil replacement in weanling pig diets | |
| Utama et al. | Utilization of dietary maggot frass on the performance, carcass percentage, digestive organs, and economic value of muscovy ducks | |
| Chen et al. | A mixed animal and plant protein source replacing fishmeal affects bile acid metabolism and apoptosis in largemouth bass (Micropterus salmoides) | |
| CN101045055A (en) | Pipecolic acid-containing antidiabetic compositions | |
| Tugiyanti et al. | The effect of breadfruit leaf flour (Artocarpus altilis) on number of blood cells and correlation between cholesterol blood and meat of Tegal ducks 10 weeks age | |
| JPWO2013099364A1 (en) | Cholesterol excretion enhancer and neutral fat excretion enhancer using sunflower inner stem fiber | |
| Hu et al. | Nutritional evaluation of genetically modified rice expressing human lactoferrin gene | |
| EP1429794A1 (en) | Weight reduction and maintenance method for animals |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 2006531398 Country of ref document: JP |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |